TECHNOPATH partner with Luminex® Corporation to offer a comprehensive range of molecular assays for respiratory, gastrointestinal and bloodstream testing, in addition to womens’ health.
Luminex® is the only molecular diagnostics developer providing both targeted and syndromic clinical tests for infectious diseases — so you never have to compromise on diagnostic performance, cost, or turnaround time to generate results.
From low-volume microbiology labs to high-capacity reference labs and everything in between, Luminex® offers flexible solutions to meet the clinical, operational, and economical needs of your healthcare system.
Molecular SARS-CoV-2 Testing Solutions
The NxTAG® Respiratory Pathogen Panel + SARS-CoV-2 (NxTAG® RPP + SARS-CoV-2) is a qualitative test for the detection of nucleic acids from multiple respiratory viruses and bacteria in nasopharyngeal swabs, oropharyngeal swabs, nasal swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal aspirates, and nasal washes. This assay is designed for use on the MAGPIX® System. Comprehensive Panel: Detects 20 viral pathogens, including SARS-CoV-2 (ORF1ab and M gene) and 3 bacterial pathogens, in a single well—enabling thorough respiratory health analysis.
For more targeted coronavirus testing in moderate-complexity labs, the ARIES® SARS-CoV-2 Assay is a sample-to-answer test that detects SARS-CoV-2 in nasopharyngeal swabs.